Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest

BACKGROUND: The purpose of this study was to investigate the endometrial safety of an oral contraceptive containing estradiol valerate/dienogest (E(2)V/DNG) administered as an estrogen step-down and progestogen step-up regimen in women of reproductive age (18–50 years), using histological assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitzer, Johannes, Parke, Susanne, Roemer, Thomas, Serrani, Marco
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089431/
https://www.ncbi.nlm.nih.gov/pubmed/21573149
http://dx.doi.org/10.2147/IJWH.S18735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089431/
https://www.ncbi.nlm.nih.gov/pubmed/21573149
http://dx.doi.org/10.2147/IJWH.S18735

Ejemplares similares